Knee osteoarthritis is a complex condition, and selecting effective non-drug treatments like orthoses or exercise is often difficult and imprecise. This study will follow individuals with early-stage knee osteoarthritis or previous anterior cruciate ligament injury to develop computational models that predict cartilage degeneration and pain over time. The models will integrate data from medical imaging, movement analysis, muscle strength testing, pain assessments, questionnaires, and biomarkers to improve personalized treatment planning.
Study Type
OBSERVATIONAL
Enrollment
105
Aalborg University Hospital
Aalborg, North Denmark, Denmark
RECRUITINGAalborg University
Aalborg, Northen Denmark, Denmark
RECRUITINGChange in Knee Cartilage Composition and Structure Assessed by Quantitative Magnetic Resonance Imaging
Person-specific 3T MRI scans will be used to measure changes in knee cartilage, including T1ρ and T2 relaxation times and 3D geometry, as indicators of cartilage biochemical composition and structural integrity. Analyses will be used for predictive computational modeling of cartilage degeneration.
Time frame: Data will be collected at three main time points: baseline, one-year follow-up, and three years follow-up. Additionally, a downscaled protocol will be used to follow the participants at 7- and 10 years follow-ups.
Knee Pain Intensity (Visual Analog Scale)
Self-reported knee pain intensity using a 100-mm Visual Analog Scale anchored with "0 = no pain" and "100 = worst imaginable pain.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year follow-up.
Brief Pain Inventory Scores
Severity and interference of pain over the past 24 hours, measured on a 0-10 scale using the Brief Pain Inventory questionnaire.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year follow-up.
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Self-administered questionnaire assessing pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. Scores range from 0 (no problems) to 4 (extreme problems) for each domain.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year follow-up.
Hospital Anxiety and Depression Scale (HADS) - Total Score
14-item self-report scale assessing anxiety and depression symptoms. Total score range: 0-42; higher scores indicate worse symptoms.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Pittsburgh Sleep Quality Index (PSQI) - Global Score
19-item questionnaire assessing sleep quality over the past month. Global score range: 0-21; higher scores indicate poorer sleep quality.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Pain Catastrophizing Scale (PCS) - Total Score
13-item scale assessing catastrophic thinking related to pain. Total score range: 0-52; higher scores indicate greater pain catastrophizing.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Short Form-12 Health Survey (SF-12) - Physical Component Summary (PCS) Score
Summary measure of physical health-related quality of life. Score range: 0-100; higher scores indicate better physical health status.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Short Form-12 Health Survey (SF-12) - Mental Component Summary (MCS) Score
Summary measure of mental health-related quality of life. Score range: 0-100; higher scores indicate better mental health status.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
40-Meter Fast-Paced Walk Test - Time
Time to walk 40 meters at fastest safe pace. Measured in seconds; lower scores indicate better performance.
Time frame: Baseline, 1-year, 3-year.
30-Second Chair Stand Test - Number of Repetitions
Number of full stands from a seated position completed in 30 seconds. Higher scores indicate better performance.
Time frame: Baseline, 1-year, 3-year.
Stair Climb Test - Time
Time taken to ascend a standard set of stairs. Measured in seconds; lower scores indicate better performance.
Time frame: Baseline, 1-year, 3-year.
Timed Up-and-Go (TUG) Test - Time
Time to rise from a chair, walk 3 meters, turn, return, and sit. Measured in seconds; lower scores indicate better performance.
Time frame: Baseline, 1-year, 3-year.
3D Motion Capture - Kinematic Parameters
Joint angles and Movements patterns during movement, measured in degrees, using 3D motion capture.
Time frame: Baseline, 1-year, 3-year.
3D Motion Capture - Kinetics Parameters
Inverse dynamics calculated from movement patterns and force plates during activities, using 3D motion capture.
Time frame: Baseline, 1-year, 3-year.
Motion capture Surface Electromyography (EMG)
Muscle activation amplitude from selected lower limb muscles, measured in microvolts (µV) and processed per SENIAM guidelines.
Time frame: Baseline, 1-year, 3-year.
Pressure Pain Detection Threshold
Minimum pressure at which a sensation becomes painful, measured in kilopascals (kPa) using a computer-controlled cuff algometer. Higher values indicate reduced sensitivity to pain.
Time frame: Baseline, 1-year, 3-year.
Pressure Pain Tolerance Threshold
Maximum pressure a participant can tolerate, measured in kilopascals (kPa). Higher values indicate greater pain tolerance.
Time frame: Baseline, 1-year, 3-year.
Temporal Summation of Pain
Increase in pain intensity in response to repetitive stimulation, measured as change in pain rating on a 0-10 numeric rating scale. Higher scores indicate greater central sensitization.
Time frame: Baseline, 1-year, 3-year.
Conditioned Pain Modulation Effect
Percentage change in pain rating during a conditioning stimulus, indicating efficiency of endogenous pain inhibition. Higher percentages indicate stronger pain inhibition.
Time frame: Baseline, 1-year, 3-year.
Plasma Protein Biomarker Concentrations - Inflammatory Markers
Quantitative concentrations of inflammatory biomarkers in plasma using LC-MS/MS and high-multiplex immunoassays (Olink). Higher or lower values indicate changes in inflammatory status.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Plasma Protein Biomarker Concentrations - Cartilage Metabolism Markers
Quantitative concentrations of cartilage metabolism biomarkers in plasma. Higher or lower values indicate changes in cartilage turnover.
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Synovial Fluid Protein Biomarker Concentrations - Inflammatory Marker
Quantitative concentrations of inflammatory biomarkers in synovial fluid
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
Synovial Fluid Protein Biomarker Concentrations - Cartilage Metabolism Markers
Quantitative concentrations of cartilage metabolism biomarkers in synovial fluid
Time frame: Baseline, 1-year, 3-year, 7-year, 10-year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.